Clinical pharmacology

Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update
Davide Capodanno

Heart Dec 2018, 104 (23) 1976-1983; DOI: 10.1136/heartjnl-2017-312228
Heart transplantation: organisational aspects and current trends in immunosuppression—a view from Spain
Luis Alonso-Pulpón, Javier Segovia, Manuel Gómez-Bueno, Pablo García-Pavía

Heart Jun 2012, 98 (11) 878-889; DOI: 10.1136/heartjnl-2011-300479
Antiplatelet therapy in percutaneous coronary intervention: is variability of response clinically relevant?
Nick Curzen, Nalyaka Sambu

Heart Sep 2011, 97 (17) 1433-1440; DOI: 10.1136/hrt.2010.206508
New P2Y₁₂ inhibitors
Robert F Storey

Heart Aug 2011, 97 (15) 1262-1267; DOI: 10.1136/hrt.2009.184242
Optimal medical management around the time of surgery
Michiel T Voûte, Tamara A Winkel, Don Poldermans

Heart Nov 2010, 96 (22) 1842-1848; DOI: 10.1136/hrt.2008.151480
Amiodarone: an effective antiarrhythmic drug with unusual side effects
Lieselot van Erven, Martin J Schalij

Heart Oct 2010, 96 (19) 1593-1600; DOI: 10.1136/hrt.2008.152652
Antiplatelet therapy during surgery
Helge Möllmann, Holger M Nef, Christian W Hamm

Heart Jun 2010, 96 (12) 986-991; DOI: 10.1136/hrt.2008.155655
Triple antithrombotic management after stent implantation: when and how?
Albert Schömig, Nikolaus Sarafoff, Melchior Seyfarth

Heart Aug 2009, 95 (15) 1280-1285; DOI: 10.1136/hrt.2008.160457

Main menu